Ultragenyx Pharmaceutical Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

598,924

Value ($000)

13,775

Weight

0.0%

2014 Q1 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	13,775	0.0%	598,924	12/31/2025
2025 Q3	11/10/2025	18,053	0.0%	600,160	9/30/2025
2025 Q2	8/12/2025	22,397	0.0%	615,969	6/30/2025
2025 Q1	9/15/2025	21,477	0.0%	593,121	3/31/2025
2024 Q4	2/6/2025	25,816	0.0%	613,633	12/31/2024
2024 Q3	11/12/2024	33,026	0.0%	594,521	9/30/2024
2024 Q2	8/12/2024	22,096	0.0%	537,616	6/30/2024
2024 Q1	5/9/2024	22,616	0.0%	484,381	3/31/2024
2023 Q4	2/6/2024	22,563	0.0%	471,825	12/31/2023
2023 Q3	11/8/2023	14,143	0.0%	396,725	9/30/2023
2023 Q2	8/10/2023	17,402	0.0%	377,238	6/30/2023
2023 Q1	5/12/2023	14,876	0.0%	370,962	3/31/2023
2022 Q4	2/13/2023	17,247	0.0%	372,274	12/31/2022
2022 Q3	11/14/2022	15,120	0.0%	365,106	9/30/2022
2022 Q2	8/15/2022	32,881	0.0%	551,126	6/30/2022
2022 Q1	5/13/2022	39,269	0.0%	540,744	3/31/2022
2021 Q4	2/11/2022	44,247	0.0%	526,183	12/31/2021
2021 Q3	11/16/2021	46,345	0.0%	513,849	9/30/2021
2021 Q2	8/16/2021	47,399	0.0%	497,101	6/30/2021
2021 Q1	5/17/2021	68,252	0.0%	599,431	3/31/2021
2020 Q4	2/16/2021	75,206	0.0%	543,274	12/31/2020
2020 Q3	11/13/2020	40,454	0.0%	492,194	9/30/2020
2020 Q2	8/20/2020	29,317	0.0%	374,792	6/30/2020
2020 Q1	5/15/2020	15,244	0.0%	343,099	3/31/2020
2019 Q4	2/7/2020	14,333	0.0%	335,579	12/31/2019
2014 Q2	7/30/2014	666	0.0%	14,828	6/30/2014
2014 Q1	4/29/2014	246	0.0%	5,024	3/31/2014